It was reported that the nav6 filter was placed in the popliteal artery without issue using the barewire.A non-abbott 4.0x60 intravascular lithotripsy balloon was advanced over the barewire and balloon dilatation was performed at the superficial femoral artery.An attempt was made to pull the ivl balloon off the barewire; however it was stuck on the wire.As the ivl was stuck on the wire, a retrieval catheter was unable to be used to retrieve the filter; therefore the entire system had to be removed all together (barewire, ivl, nav6).A drug coated balloon was advanced over a different guide wire to further treat the vessel.A final angiogram was taken and a distal embolism was noted in the foot.The procedure was prolonged as tpa medication was intravascularly injected to treat the embolism.In the physicians opinion, the nav6 did not cause the embolism.No additional information was provided.
|
Visual analysis was performed on the returned product.The reported difficult to remove was unable to be tested due to device condition.Lot history record (lhr) and corrective and preventive actions (capa) reviews were performed and revealed no indication of a product quality issue.Additionally, a query of the complaint handling database for the reported lot revealed there is no indication of a lot specific issue.Based on the reported event description and evaluation of the returned unit, the reported difficulty removing appears to be due to circumstances of the procedure.It is likely that clearance between the guide wire lumen of the non-abbott ivl (intravascular lithotripsy) balloon catheter and the barewire was reduced during use causing the devices to become stuck requiring that the entire system be removed together.A definitive cause for the embolism could not be determined; however, in the physician¿s opinion, the nav6 did not cause the embolism.Reportedly, tpa medication was intravascularly injected to treat the embolism.The reported patient effect of embolism is listed in the emboshield nav 6 instruction for use (eifu) as a known potential adverse effect associated with the use of carotid stents and embolic protection systems.There is no indication of a product quality issue with respect to the design, manufacture, or labeling of the device.
|